Novo Nordisk's Main Europe Problem Is Reimbursement

May 1 (Bloomberg) -- Jesper Brandgaard, chief financial officer of Novo Nordisk A/S, discusses its Tresiba diabetes treatment, European Medicines Agency concerns about its diabetes treatment Victoza and challenges in the European market. He speaks from Copenhagen with Francine Lacqua and Caroline Hyde on Bloomberg Television's "On the Move." (Source: Bloomberg)
Hacker Teen Uses 'Swatting' to Harass Online Gamers
37:07 - Bloomberg's Emily Chang reports on the teenage hacker who admitted to "swatting" online gamers. She speaks on "Bloomberg West." (Source: Bloomberg)
  • How Close Are We to an Uber IPO?
  • The Top Three Things to Watch for at Google I/O
  • U.S. Economy Set Up for Sept. or Oct. Rate Hike: Kleintop